Skip to main content Skip to main navigation menu Skip to site footer
PAGEPress
  • Bluesky
  • X
  • LinkedIn
Reumatismo
  • Search
  • Contacts
  • News
  • Register
  • Login
  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Early Access
  • Archives
    • Overview
  • Search
  • Contacts
  • News
  • Register
  • Login
  1. Home /
  2. Search

Search

Advanced filters Clear filters
Published After
Published Before

Search Results

7 results

  • Treatment patterns of snti-TNF agents in Italy: an observational study

    L. Punzi, M. Matucci Cerinic, F. Cantini, G. Bagnato, U. Fiocco, C. Ferri, S. Bombardieri

    Pages 18-28

    DOI https://doi.org/10.4081/reumatismo.2011.18

    • 1,517 abstract views
    • 1,142 PDF
  • Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects

    C. Botsios, P. Ostuni, P. Sfriso, A. Furlan, U. Fiocco, D. Sgarabotto, S. Todesco

    Pages 224-235

    DOI https://doi.org/10.4081/reumatismo.2003.224

    • 1,426 abstract views
    • 2,915 PDF
  • Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis

    C. Botsios, P. Sfriso, A. Furlan, P. Ostuni, M. Biscaro, U. Fiocco, S. Todesco, L. Punzi

    Pages 32-37

    DOI https://doi.org/10.4081/reumatismo.2007.32

    • 2,067 abstract views
    • 955 PDF
  • Intra-articular etanercept treatment for severe diffuse pigmented villonodular knee synovitis

    U. Fiocco, P. Sfriso, F. Oliviero, F. Sovran, E. Scagliori, E. Pagnin, M. Vezzù, L. Cozzi, C. Botsios, R. Nardacchione, A. Di Maggio, L. Rubaltelli, C. Giacometti, F. Calabrese, S. Todesco

    Pages 268-274

    DOI https://doi.org/10.4081/reumatismo.2006.268

    • 1,942 abstract views
    • 2,882 PDF
  • Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatement with infliximab

    A. Hoxha, A. Ruffatti, P. Grypiotis, M. Podswiadek, C. Botsios, U. Fiocco, L. Punzi, S. Todesco

    Pages 121-126

    DOI https://doi.org/10.4081/reumatismo.2006.121

    • 2,243 abstract views
    • 1,884 PDF
  • Differences in pharmacology of tumor necrosis factor (TNF) antagonists

    U. Fiocco, S. Bombardieri

    Pages 8-16

    DOI https://doi.org/10.4081/reumatismo.2005.4s.8

    • 1,485 abstract views
    • 1,921 PDF
  • IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy

    U. Fiocco, M. Vezzù, L. Cozzi, S. Todesco

    Pages 62-73

    DOI https://doi.org/10.4081/reumatismo.2004.1s.62

    • 1,631 abstract views
    • 2,109 PDF
1 - 7 of 7 items

Submit your article

Read the guidelines for authors before you start your submission.

Make a Submission

authors

FOR AUTHORS
  • ARTICLE PROCESSING CHARGE
  • Guide for Authors
  • Benefits for Authors
  • How to write a scientific paper
  • How to write a Review article

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to review
  • Thanks to Reviewers

Categories

    • Abstract Book
    • Oral Communications - Day 1
    • Posters - Day 1
    • Oral Communications - Day 2
    • Posters - Day 2
    • Oral Communications - Day 3

indexing

INDEXING
  • PubMed
  • Scopus
  • Web of Science
  • Google Scholar
  • OpenAlex
  • Scilit
  • DOAJ
  • Società Italiana di Reumatologia
  • Analytics

social

Follow Reumatismo on

Keywords

Reumatismo

is the Official Journal of the Italian Society of Rheumatology (SIR). Founded in 1949. Published online by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

pISSN 0048-7449
eISSN 2240-2683

The journal

  • About the Journal
  • Editorial board
  • Archives
  • Announcements
  • Contact

For authors

  • Submissions
  • Guidelines for authors
  • Privacy Statement
PAGEPress

© PAGEPress 2008–2026. PAGEPress® is a registered trademark property of PAGEPress srl, Italy. VAT IT02125780185. This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.